ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Context A number of retrospective studies report that patients with acromegaly have increased morbidity and premature mortality, with standardized mortality ratios (SMR) of 1.3-3. Many patients with acromegaly develop hypopituitarism as a result of the pituitary adenoma itself or therapies such as surgery and radiotherapy. Pituitary radiotherapy and hypopituitarism have also been associated with an increased SMR. Methods Using the West MIDLANDS: Acromegaly database (n = 501; 275 female), we assessed the influence of prior radiotherapy and hypopituitarism (and replacement therapy) on mortality in patients with acromegaly. Median duration of follow-up was 14.0 yr (interquartile range, 7.9-21 yr). Results All-cause mortality was elevated [SMR, 1.7 (1.4, 2.0); P Conclusions Radiotherapy and ACTH deficiency are significantly associated with increased mortality in patients with acromegaly. In ACTH-deficient patients, a daily dose of more than 25 mg hydrocortisone is associated with increased mortality compared to lower doses. These results have important implications for the treatment of patients with acromegaly and also raise issues as to the optimum hydrocortisone treatment regimens for ACTH-deficient patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher GC replacement doses in patients with ACTH deficiency are associated with increased overall and cardiovascular mortality; the greatest risk is in patients receiving daily HC doses higher or equal to 30 mg (8).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [8]
In the citing paper
“Higher GC replacement doses in patients with ACTH deficiency are associated with increased overall and cardiovascular mortality; the greatest risk is in patients receiving daily HC doses higher or equal to 30 mg (8).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [8]
In the citing paper
“It has become increasingly evident that, even in patients with treated AI, there continues to be significant morbidity and reduced life expectancy.5–7”
From Adrenal crisis: prevention and management in adult patients (2019) · cites this paper as [6]
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Self-citation11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationMortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Statistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170 · Cited by 777
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730
Factors Influencing Mortality in Acromegaly
Holdaway, I. M., Rajasoorya, R. C., & Gamble, G. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031199 · Cited by 651
Research works printed but not linked: 1
- Fajardo, 1999, Is the pathology of radiation injury different in small vs large blood vessels?, Cardiovasc Radiat Med, 1, 108
Cited by
Items 101–200 of 201
Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments
Johannsson, G., Skrtic, S., Lennernäs, H., Quinkler, M., & Stewart, P. M. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.925865 · Cited by 21
Self-citationThe management of glucocorticoid deficiency: Current and future perspectives
Dineen, R., Martin‐Grace, J., Thompson, C. J., & Sherlock, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.006 · Cited by 21
Self-citationHigh mortality risk among women with acromegaly still persists
Galoiu, S. A., Toma, I.-D., Tanasie, D., Bărbulescu, A., Baciu, I. F., Niculescu, D., Trifanescu, R. A., Capatina, C. A.-M., Radian, S., & Poiană, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1348972 · Cited by 21
Hypothalamic–pituitary organoid generation through the recapitulation of organogenesis
Ozaki, H., Suga, H., & Arima, H. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12719 · Cited by 21
Predictors of acromegaly-associated mortality
Ben-Shlomo, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.267 · Cited by 20
Yedinak, C. G., Cetas, I., Ozpinar, A., McCartney, S., Dog⫧an, A., & Fleseriu, M. (2016) · Endocrine · doi:10.1007/s12020-016-1042-2 · Cited by 20
Sherlock, M., Behan, L., Hannon, M. J., Alonso, A. A., Thompson, C. J., Murray, R. D., Crabtree, N. J., Hughes, B. A., Arlt, W., Agha, A., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0490 · Cited by 19
Self-citationAcromegaly and Cancer: An Update
Danilowicz, K., & Sosa, S. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102914 · Cited by 19
Ayuk, J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04300.x · Cited by 18
Self-citationStem Cells in Neuroendocrinology
Pfaff, D., & Christen, Y. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8 · Cited by 17
Oh, T. K., & Song, I. (2020) · Endocrine · doi:10.1007/s12020-020-02382-6 · Cited by 17
The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
Choudhury, S., Tan, T., Lazarus, K., & Meeran, K. M. (2021) · Endocrine Connections · doi:10.1530/ec-20-0473 · Cited by 17
Radiotherapy and Mortality in Pituitary Adenomas
González‐Virla, B., Vargas‐Ortega, G., & Romero‐Gameros, C. A. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102900 · Cited by 17
Bitencourt, M. R., Batista, R. L., Biscotto, I. P., & Carvalho, L. R. S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000493 · Cited by 16
Mortality in Acromegalic Patients: Etiology, Trends, and Risk Factors
Alhawyan, F. S. (2021) · Cureus · doi:10.7759/cureus.14265 · Cited by 16
Schlechte, J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2410 · Cited by 15
Dineen, R., Martin‐Grace, J., Ahmed, K. M. S., TAYLOR, A. E. R., Shaheen, F., Schiffer, L., Gilligan, L. C., Lavery, G. G., Frizelle, I. M., Gunness, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad370 · Cited by 14
Self-citationLaway, B. A., Rasool, A., Baba, M. S., Misgar, R. A., Bashir, M. I., Wani, A. I., Choh, N. A., Shah, O. A., Lone, A. A., & Shah, Z. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14871 · Cited by 14
Bioletto, F., Sibilla, M., Gasco, V., Ghigo, E., & Grottoli, S. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02356-9 · Cited by 14
Newell-Price, J. D. C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.118 · Cited by 14
Sherlock, M., & Stewart, P. M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01317 · Cited by 13
Self-citationManagement of persistent acromegaly following primary therapy: The current landscape in the UK
Kyriakakis, N., Seejore, K., Hanafy, A., & Murray, R. D. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.158 · Cited by 13
Ramadoss, V., Lazarus, K., Prevost, A. T., Tan, T., Meeran, K. M., & Choudhury, S. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab147 · Cited by 12
Application of pluripotent stem cells for treatment of human neuroendocrine disorders
Suga, H. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2880-4 · Cited by 12
Sex differences in mortality in patients with acromegaly: a nationwide cohort study in Korea
Kim, J., Hong, N., Choi, J., Moon, J. H., Kim, E. H., Hong, J. W., Lee, E. J., Kim, S. G., & Ku, C. R. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad106 · Cited by 12
Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions
Kienitz, T., Hahner, S., Burger‐Stritt, S., & Quinkler, M. O. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1217-7208 · Cited by 11
Outcomes of the short Synacthen test: what is the role of the 60 min sample in clinical practice?
Dineen, R., Mohamed, A. H. H., Gunness, A., Rakovac, A., Cullen, E., Barnwell, N., Neary, C., Behan, L., Boran, G. P., Gibney, J., et al. (2019) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-136669 · Cited by 10
Self-citationHealthcare cost and survival in patients with non-functioning pituitary adenoma
Olsson, D. S., Svensson, M., Labori, F., Geer, A. D., & Johannsson, G. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad057 · Cited by 10
Hypopituitarism and Growth Hormone Deficiency
Burt, M. G., & Ho, K. K. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00011-1 · Cited by 10
Vulto, A., Minović, I., de Vries, L. V., Timmermans, A. C., van Faassen, M. H. J. R., Neto, A. W. G., Touw, D. J., de Jong, M. F. C., van Beek, A. P., Dullaart, R. P. F., et al. (2020) · Clinical Transplantation · doi:10.1111/ctr.13824 · Cited by 9
Updates in growth hormone treatment and mortality
Sherlock, M., & Stewart, P. M. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328363184d · Cited by 9
Self-citationPituitary disease mortality: is it fiction?
Erfurth, E. M., Siesjö, P., & Björk‐Eriksson, T. (2013) · Pituitary · doi:10.1007/s11102-013-0469-1 · Cited by 9
Long-term safety of gamma knife radiosurgery (SRS) for acromegaly
Sims-Williams, H. P., Rajapaksa, K., Yianni, J., Walton, L., Sinha, S. K., Radatz, M. W. R., Herbert, E., Bradburn, M. J., & Newell-Price, J. D. C. (2021) · Pituitary · doi:10.1007/s11102-021-01149-0 · Cited by 9
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly
Ronchi, C. L., Verrua, E., Ferrante, E., Bender, G., Sala, E., Lania, A. G., Faßnacht, M., Beck-Peccoz, P., Allolio, B., Spada, A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1105 · Cited by 9
Ceccato, F., Lizzul, L., Zilio, M., Barbot, M., Denaro, L., Emanuelli, E., Alessio, L., Rolma, G., Manara, R., Saller, A., et al. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-103933 · Cited by 9
Postoperative use of somatostatin analogs and mortality in patients with acromegaly
Postma, M. R., Wolters, T. L. C., van den Berg, G., van Herwaarden, A. E., Kobold, A. C. M., Sluiter, W. J., Wagenmakers, M. A. E. M., van den Bergh, A. C. M., Wolffenbuttel, B. H. R., Hermus, A. R., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0166 · Cited by 9
Jørgensen, N. T., Erichsen, T. M., Jørgensen, M. B., Idorn, T., Feldt‐Rasmussen, B., Holst, J. J., Feldt‐Rasmussen, U., & Klose, M. (2023) · Pituitary · doi:10.1007/s11102-022-01297-x · Cited by 9
Donald, D. M., McDonnell, T., O’Reilly, M., & Sherlock, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09897-7 · Cited by 8
Self-citationSuga, H. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-41603-8_4 · Cited by 8
Ceccato, F., Selmin, E., Antonelli, G., Barbot, M., Daniele, A., Boscaro, M., Plebani, M., & Scaroni, C. M. (2021) · Endocrine Connections · doi:10.1530/ec-21-0404 · Cited by 7
Glucocorticoid replacement therapies: past, present and future
Liew, S.-Y., Akker, S. A., Guasti, L., & Pittaway, J. F. H. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.011 · Cited by 8
Donangelo, I., & Melmed, S. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10034-4 · Cited by 7
Mortality and pituitary disease
Stewart, P. M., & Sherlock, M. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.03.026 · Cited by 7
Self-citationWoodmansee, W. W., Gordon, M. B., Molitch, M. E., Ioachimescu, A. G., Carver, D. W., Mirakhur, B., Cox, D., & Salvatori, R. (2018) · Endocrine · doi:10.1007/s12020-018-1615-3 · Cited by 7
Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism
Peacey, S. R., Wright, D., Aye, M., & Moisey, R. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04314.x · Cited by 6
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Making pituitary hormone-producing cells in a dish [Review]
Suga, H. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0232 · Cited by 6
The Association of Hydrocortisone Dosage on Mortality in Infants Born Extremely Premature
Tolia, V. N., Bahr, T. M., Bennett, M., Martin, G., Greenberg, R. G., Laughon, M. M., & Clark, R. H. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.11.023 · Cited by 6
Eng, P. C., Ramadoss, V., Tan, L. Y. L., Ong, L. Z., Deepak, D. S., & Khoo, C. M. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.10.006 · Cited by 5
Tritos, N. A., Carlsson, M. O., Vila, G., Jiménez, C., Torre, D. L., Wajnrajch, M. P., Biller, B. M. K., Cespedes, L. M., & Miller, K. K. (2025) · Endocrine Connections · doi:10.1530/ec-25-0247 · Cited by 5
Heart Rate Variability in Postoperative Patients with Nonfunctioning Pituitary Adenoma
Ha, J., Baek, H.-S., Jeong, C., Yeo, M., Lee, S., Cho, J., Baek, K., Kang, M. I., & Lim, D. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.978 · Cited by 4
Changing understanding of acromegaly epidemiology and early mortality risk
Espósito, D., & Johannsson, G. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag150 · Cited by 4
Melmed, S. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00012-3 · Cited by 4
Outcome of complications in acromegaly patients after long-term disease remission
Claessen, K. M. J. A., Pereira, A. M., & Biermasz, N. R. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1068116 · Cited by 4
Individualized acromegaly treatment: Is stereotactic radiation therapy changing the paradigm?
Liu, W., & Fleseriu, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1034576 · Cited by 3
Pituitary Dysfunction as a Cause of Cardiovascular Disease
Gogakos, A. I., Gogakos, T., Kita, M. D., & Efstathiadou, Z. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612824999201105165351 · Cited by 3
Synacthen Stimulation Test Following Unilateral Adrenalectomy Needs to Be Interpreted With Caution
Zaman, S., Almazrouei, R. A., Sam, A. H., Marco, A. N. D., Todd, J. F., Palazzo, F. F., Tan, T., Dhillo, W. S., Meeran, K. M., & Wernig, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.654600 · Cited by 3
Melmed, S. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00010-x · Cited by 3
Melmed, S. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10014-8 · Cited by 3
Diagnosis, treatment and clinical perspectives of acromegaly
Roelfsema, F., & van den Berg, G. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1096770 · Cited by 2
Revisiting mortality in acromegaly using machine learning
Sulu, C., Onay, G., Bakhdiyarli, G., Şahin, S., Durcan, E., Kara, Z., Demir, A. N., Martin, O., Özkaya, H. M., Tanrıöver, N., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04422-5 · Cited by 2
Jayasena, C. N., Izzi‐Engbeaya, C. N., Narayanaswamy, S., Modi, M., Clarke, H., Nijher, G. M. K., Meeran, K. M., & Dhillo, W. S. (2015) · Clinical Endocrinology · doi:10.1111/cen.12685 · Cited by 2
Update on the use of oral octreotide therapy for acromegaly
Schilbach, K., & Schopohl, J. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1199954 · Cited by 2
Optimising glucocorticoid replacement in adrenal insufficiency
Meeran, K. M. (2019) · British Journal of Diabetes · doi:10.15277/bjd.2019.229 · Cited by 2
Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
Ha, J., Kim, K. M., Lim, D., Song, K., & Seo, G. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144799 · Cited by 2
Haver, N., Halperin, R., Bar-On, Y., Tripto‐Shkolnik, L., Badarne, M., & Tirosh, A. (2024) · HORMONES · doi:10.1007/s42000-024-00578-3 · Cited by 2
Hipofiz adenomlarında Radyoterapi
Gürsoy, G., & Demirbaş, B. (2019) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · Cited by 2
Glucocorticoids - outcome in patients with glucocorticoid deficiency and Cushing's syndrome
Ragnarsson, Ó. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Nolan, J. D., Brown, S. J., Henley, D., & Lim, E. M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf424 · Cited by 1
Computed Tomography Cardiac Angiography Findings in Patients With Sheehan Syndrome
Mohammad, A., Jehangir, M., Mir, S. A., Fatima, S. A., Baba, M. S., Laway, B. A., Bhat, J. A., & Shafi, N. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.04.006 · Cited by 1
Mutlu, Ü., Rasulova, N., Hacışahinoğulları, H., Yalın, G. Y., Gül, N., Üzüm, A. K., & Selçukbiricik, Ö. S. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02668-4 · Cited by 1
Acromegaly and clinical manifestations
Villar‐Taibo, R., Fernández-Rodríguez, E., & Bernabéu, I. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2025.10.004 · Cited by 1
Obesity and Metabolic Disturbances in Adamantinomatous Craniopharyngioma Patients
Erfurth, E. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-51890-9_6 · Cited by 1
Owolabi, M., Malone, M. A., & Merritt, A. (2024) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2024.04.004 · Cited by 1
Daniel, E. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Experience using temozolomide in the treatment of aggressive pituitary adenomas
Kalinin, P. L., Астафьева, Л. И., Chernov, I. V., Kobyakov, G. L., Fomichev, D. V., & Trunin, Y. Y. (2025) · Russian journal of neurosurgery · doi:10.17650/1683-3295-2024-26-4-54-64 · Cited by 1
Li, T., Li, S., Liu, H., Tan, H., Li, J., Li, J., & Yu, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3912731/v1
Investigação de potenciais biomarcadores no diagnóstico da insuficiência adrenal central
Bitencourt, M. R. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-25042024-153831
Tritos, N. A., & Klibanski, A. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch12
(2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833c4b2b
Rodríguez, E. F. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Suga, H., & Ozone, C. (2017) · Springer eBooks · doi:10.1007/978-981-10-3768-9_3
Postoperative use of somatostatin analogs and mortality in patients with acromegaly
Postma, M. R., Wolters, T. L. C., van, D. B. G., van, H. A., Kobold, A. C. M., Sluiter, W. J., Wagenmakers, M. A. E. M., van, D. B. A. C., Wolffenbuttel, B. H. R., Hermus, A. R., et al. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.oc13.1
Predictors of Overall Mortality in Pituitary Adenomas
Toma, I.-D., Niculescu, D., Trifanescu, R. A., Galoiu, S. A., & Poiană, C. (2026) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2970-2015
Mortality and Morbidity in Acromegaly: Impact of Disease Control
Holdaway, I. M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-317-6_16
Cardiovascular and Metabolic Comorbidities in Pituitary Disorders
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5034-2
Personalized medical treatment for pituitary adenoma
Ceccato, F. (2019) · Padua@research (University of Padova)
Passos, G. B. D. M., dos Santos, F. A. C., & Bernardo, P. A. V. D. C. (2026) · International Journal of Health Science · doi:10.22533/at.ed.01596122607102
Abdulhadi, B., Farmer, C. C., & Vaughan, T. B. (2022) · Contemporary Endocrinology · doi:10.1007/978-3-031-16258-9_11
Fougner, S. L. (2010) · NVA (Nasjonalt vitenarkiv)
Santana, P. H. G., Souza, R. T. V., Filho, D. M., de Oliveira, L. F., Raminelli, A. O., Marques, B. L., & Parreira, R. C. (2024) · Conexão Ciência (Online) · doi:10.24862/cco.v19i3.1882
Densità minerale ossea nel paziente acromegalico: risultati di uno studio di coorte.
ALOISI, G. (2017) · Electronic Theses and Dissertations Repository (University of Pisa)
Stem Cells in Neuroendocrinology
(2016) · Directory of Open access Books (OAPEN Foundation)
Abstracts of the ICARE 2026 80th SIAARTI National Congress
(2026) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-026-00440-5
CDA-AMC (2025) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2025.1277
Cappellani, D. (2014) · Electronic Theses and Dissertations Repository (University of Pisa)
Effetti delle terapie mediche dell'acromegalia sul metabolismo glicemico e sulla mortalità
Urbani, C. (2014) · Electronic Theses and Dissertations Repository (University of Pisa)
Bolfi, F. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Sherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom
- Keele University (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, P. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-11-01
- Volume
- 94
- Issue
- 11
- Pages
- 4216-4223
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2079605343
- Semantic Scholar
- 2edc859ca1b96cf7ca9a2a1af8b57d431f6d7a0e
- Cited by
- 185
- References
- 56
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 12 · 2023: 9 · 2022: 11 · 2021: 14 · 2020: 8 · 2019: 10 · 2018: 14 · 2017: 9 · 2016: 22 · 2015: 12 · 2014: 11 · 2013: 10 · 2012: 13
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Cancer Research UK
- National Institute for Health and Care Research (NF-SI-0508-10356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Clinical Neurology › Meningioma and schwannoma management
- Keywords
- acromegaly, ACTH deficiency, hydrocortisone replacement, hydrocortisone dose, pituitary radiotherapy, hypopituitarism, gonadotropin deficiency, all-cause mortality, standardized mortality ratio, pituitary adenoma, TSH deficiency, mortality risk factors, long-term follow-up
- MeSH terms
- Acromegaly, Adrenocorticotropic Hormone, Cardiovascular Diseases, Cause of Death, Female, Follow-Up Studies, Humans, Hydrocortisone, Male, Neoplasms, Predictive Value of Tests, Radiotherapy, Respiratory Tract Diseases, Time Factors, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.